Agilent Technologies, Inc.

NYSE

Market Cap.

39B

Avg. Volume

1.77M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Agilent Technologies, Inc.

Agilent Technologies, Inc. News

Agilent Technologies, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
agilent.com

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Agilent Technologies, Inc. Earnings & Revenue

Agilent Technologies, Inc. Financials

Table Compare

Compare A metrics with:

   

Earnings & Growth

A

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

A

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

A

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

A

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Agilent Technologies, Inc. Income

Agilent Technologies, Inc. Balance Sheet

Agilent Technologies, Inc. Cash Flow

Agilent Technologies, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Agilent Technologies, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.9560

Payment DateDividendFrequency
2025-01-220.248Quarterly
2024-10-230.236Quarterly
2024-07-240.236Quarterly
2024-04-240.236Quarterly
2024-01-240.236Quarterly

Agilent Technologies, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Agilent Technologies, Inc. Executives

NameRole
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global Communications
Ms. Yvonne MackieMD of UK & Ireland Operations and Vice President of Human Resources - Europe
Mr. Rodney GonsalvesPrincipal Accounting Officer, Vice President & Corporate Controller
Mr. Philip BinnsSenior Vice President of Agilent and President of Life Sciences & Applied Markets Group
Mr. Bret M. DiMarcoSenior Vice President, Chief Legal Officer, & Secretary
NameRoleGenderDate of BirthPay
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global CommunicationsMale1959936.31K
Ms. Yvonne MackieMD of UK & Ireland Operations and Vice President of Human Resources - EuropeFemale

--

Mr. Rodney GonsalvesPrincipal Accounting Officer, Vice President & Corporate ControllerMale1966

--

Mr. Philip BinnsSenior Vice President of Agilent and President of Life Sciences & Applied Markets GroupMale

--

Mr. Bret M. DiMarcoSenior Vice President, Chief Legal Officer, & SecretaryMale1968

--

Agilent Technologies, Inc. Insider Trades

Date29 Nov
NameAncher-Jensen Henrik
RoleSr Vice President
TransactionDisposed
TypeF-InKind
Shares2577
Date27 Nov
NameGonsalves Rodney
RoleV.P., Corporate Controller
TransactionAcquired
TypeA-Award
Shares1365
Date27 Nov
NameGonsalves Rodney
RoleV.P., Corporate Controller
TransactionAcquired
TypeA-Award
Shares3941
Date27 Nov
NameMcMahon Robert W.
RoleSr. VP and CFO
TransactionAcquired
TypeA-Award
Shares6423
Date27 Nov
NameMcMahon Robert W.
RoleSr. VP and CFO
TransactionAcquired
TypeA-Award
Shares18544
DateNameRoleTransactionTypeShares
29 NovAncher-Jensen HenrikSr Vice PresidentDisposedF-InKind2577
27 NovGonsalves RodneyV.P., Corporate ControllerAcquiredA-Award1365
27 NovGonsalves RodneyV.P., Corporate ControllerAcquiredA-Award3941
27 NovMcMahon Robert W.Sr. VP and CFOAcquiredA-Award6423
27 NovMcMahon Robert W.Sr. VP and CFOAcquiredA-Award18544

Discover More

Streamlined Academy

Agilent Technologies, Inc.

NYSE

Market Cap.

39B

Avg. Volume

1.77M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Agilent Technologies, Inc. News

Agilent Technologies, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Agilent Technologies, Inc. Earnings & Revenue

Agilent Technologies, Inc. Income

Agilent Technologies, Inc. Balance Sheet

Agilent Technologies, Inc. Cash Flow

Agilent Technologies, Inc. Financials Over Time

Agilent Technologies, Inc. Executives

NameRole
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global Communications
Ms. Yvonne MackieMD of UK & Ireland Operations and Vice President of Human Resources - Europe
Mr. Rodney GonsalvesPrincipal Accounting Officer, Vice President & Corporate Controller
Mr. Philip BinnsSenior Vice President of Agilent and President of Life Sciences & Applied Markets Group
Mr. Bret M. DiMarcoSenior Vice President, Chief Legal Officer, & Secretary
NameRoleGenderDate of BirthPay
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global CommunicationsMale1959936.31K
Ms. Yvonne MackieMD of UK & Ireland Operations and Vice President of Human Resources - EuropeFemale

--

Mr. Rodney GonsalvesPrincipal Accounting Officer, Vice President & Corporate ControllerMale1966

--

Mr. Philip BinnsSenior Vice President of Agilent and President of Life Sciences & Applied Markets GroupMale

--

Mr. Bret M. DiMarcoSenior Vice President, Chief Legal Officer, & SecretaryMale1968

--

Agilent Technologies, Inc. Insider Trades

Date29 Nov
NameAncher-Jensen Henrik
RoleSr Vice President
TransactionDisposed
TypeF-InKind
Shares2577
Date27 Nov
NameGonsalves Rodney
RoleV.P., Corporate Controller
TransactionAcquired
TypeA-Award
Shares1365
Date27 Nov
NameGonsalves Rodney
RoleV.P., Corporate Controller
TransactionAcquired
TypeA-Award
Shares3941
Date27 Nov
NameMcMahon Robert W.
RoleSr. VP and CFO
TransactionAcquired
TypeA-Award
Shares6423
Date27 Nov
NameMcMahon Robert W.
RoleSr. VP and CFO
TransactionAcquired
TypeA-Award
Shares18544
DateNameRoleTransactionTypeShares
29 NovAncher-Jensen HenrikSr Vice PresidentDisposedF-InKind2577
27 NovGonsalves RodneyV.P., Corporate ControllerAcquiredA-Award1365
27 NovGonsalves RodneyV.P., Corporate ControllerAcquiredA-Award3941
27 NovMcMahon Robert W.Sr. VP and CFOAcquiredA-Award6423
27 NovMcMahon Robert W.Sr. VP and CFOAcquiredA-Award18544

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
agilent.com

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Agilent Technologies, Inc.

Agilent Technologies, Inc. Financials

Table Compare

Compare A metrics with:

   

Earnings & Growth

A

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

A

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

A

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

A

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Agilent Technologies, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.9560

Payment DateDividendFrequency
2025-01-220.248Quarterly
2024-10-230.236Quarterly
2024-07-240.236Quarterly
2024-04-240.236Quarterly
2024-01-240.236Quarterly

Agilent Technologies, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)